This study is looking at the best way to treat a common heart condition called Patent Ductus Arteriosus (PDA) in very premature babies. PDA is when a blood vessel that's open during pregnancy doesn't close after birth, which can lead to health problems. Researchers are testing if giving ibuprofen early to these babies, when indicated by an echocardiogram (a heart ultrasound), helps. Ibuprofen is a common medication used for PDA, but it can also have side effects in very premature infants. This study aims to enroll 100 infants who are born before 26 weeks of pregnancy and are up to 72 hours old. The main goals are to see how many eligible infants join the study and how many follow the study plan without issues. The study's current status is unclear.

Study design

This is a pilot randomized controlled trial, meaning participants are assigned by chance to different treatment groups. The study plans to enroll 100 infants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoints are measured at 7 days postnatal age.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.